Clinical Trial

Concomitant Tricuspid Repair in Patients With Left Heart Surgery

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Tricuspid regurgitation is common in patients with severe left heart diseases, such as degenerative mitral regurgitation. However, the evidence base is insufficient to inform a decision about whether to perform concomitant tricuspid-valve repair during left heart surgery in patients who have mild tricuspid regurgitation. To inform decision making, we will conduct a multicenter, randomized trial to assess the benefits and risks of tricuspid-valve repair at the time of left heart diseases in patients with mild tricuspid regurgitation who were undergoing surgery for left heart surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-10-23.
Trial Details
NCT Number NCT05595187
Lead Sponsor Nanjing Medical University
Conditions Tricuspid Regurgitation, Mitral Regurgitation, Cardiopulmonary Bypass
Enrollment 400 participants
Start Date 2024-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2023-12-14